Results 101 to 110 of about 1,148 (137)

Estimated prevalence of unregistered and falsified medicinal products in Malaysia: a nationwide cross-sectional study conducted from March to November 2023. [PDF]

J Pharm Policy Pract
Abdul Karim KA, Ahmad AE, Abdullah MZ, Alias A, Setan S, Sulaiman MAA, Muhsin NI'.   +6 more
europepmc   +1 more source

Assessing the quality of antimalarial drugs in Equatorial Guinea: a follow-up study. [PDF]

BMJ Glob Health
Kaur H, Paris L, Mba Eyono JN, Nguema Avue RM, Phiri WP, Smith JM, Guerra CA, Riloha Rivas M, García GA.   +8 more
europepmc   +1 more source

Visual assessment of antimicrobial medicine packaging and labeling quality in pharmacies of Ho Municipality, Ghana. [PDF]

PLoS One
Orman E, Ankah BD, Oteng D, Mccarthur D, Aku TA, Hutton-Nyameaye AA, Jato J, Odoi H, Somuah SO, Collison-Cofie INA, Jani YH, Dodoo C.   +11 more
europepmc   +1 more source

Tiny lives, big failures: India's drug regulation crisis. [PDF]

Lancet Reg Health Southeast Asia
The Lancet Regional Health-Southeast Asia.
europepmc   +1 more source

Biochemical profiling provides a low-cost and globally accessible method to detect falsified vaccines and insulin. [PDF]

Sci Rep
Brook J, Bharucha T, Arman BY, Caillet C, Morris S, Taylor-Siddons M, Fernandez LG, Walsby-Tickle J, Legge I, Banerjee S, Deats M, Jena R, Ranade DS, Chunekar SR, Patil KD, Gairola S, Dunachie S, Merchant HA, Stokes R, Kuwana R, Maes A, Gilbert S, McCullagh J, Matousek P, Zitzmann N, Newton PN, Gangadharan B, James T.   +27 more
europepmc   +1 more source

Post-market quality monitoring of medicines in Christian Health Association of Ghana health institutions. [PDF]

Ghana Med J
Arhinful DK, Yeboah P, Duah J, Antwi MA, Attachey A, Karikari-Boateng E, Awal AM, Rinke de Wit TF, Kretchy IA.   +8 more
europepmc   +1 more source

Knowledge, practices, and recognition ability of counterfeit medicines among lebanese community pharmacists during concurrent national crises. [PDF]

Sci Rep
Mourad N, Haddad C, Sacre H, Tawil SA, Zeenny RM, Younes S, Rahal M, Mourad L, Baalbaki R, Hamdan M, Kanaan S, Salameh P.   +11 more
europepmc   +1 more source

Substandard medicines in Nepal: a crisis of access, equity, and a call for action. [PDF]

Front Public Health
Ghimire A.
europepmc   +1 more source

Drug recall, its frequencies and conclusion: a retrospective secondary analysis involving 2-year publicly available data from Nepal. [PDF]

Ther Adv Drug Saf
Barma S, Pathak N, Dhungana S, Jha PK, Shrestha S.   +4 more
europepmc   +1 more source

[Substandard and falsified medical products: 25 years of successful network collaboration among regulatory authorities in the AmericasProdutos médicos de qualidade inferior e falsificados: 25 anos de colaboração bem-sucedida em rede entre autoridades reguladoras da Região das Américas]. [PDF]

Rev Panam Salud Publica
Vahos Zambrano J, Carrasco G, Rojas-Cortés R, Alfonso MJ, Viñas R, Derecho M, Munguía M, Marin D, Castro JL, Pombo-Castro ML.   +9 more
europepmc   +1 more source